Unichem Pharmaceuticals (USA), Inc.
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Unichem Pharmaceuticals (USA), Inc. is marketing and distributing its own label generic pharmaceutical products in the United States.
Market Focus Unichem Pharmaceuticals specializes in marketing and distributing generic pharmaceutical products within the United States, indicating a targeted focus on the cost-sensitive segment of the healthcare market.
Product Recall Events Recent product recall issues, such as the mislabeled Cyclobenzaprine Tablets, highlight an area where enhanced quality assurance and regulatory compliance services could provide value.
Financial Range With revenues estimated between $10 million and $25 million, Unichem represents a mid-sized pharmaceutical company open to growth partnerships and supply chain expansion opportunities.
Technological Infrastructure Utilization of diverse tech tools like SAP and CIM Technologies suggests a sophisticated operational setup, providing potential for targeted tech solutions or integration services to streamline their distribution and manufacturing processes.
Growth Potential As a company competing with industry giants on a smaller scale, Unichem may be receptive to strategic collaborations, new product lines, or innovation-driven partnerships to strengthen its market position.
Unichem Pharmaceuticals (USA), Inc. uses 8 technology products and services including RSS, oEmbed, Google Fonts API, and more. Explore Unichem Pharmaceuticals (USA), Inc.'s tech stack below.
| Unichem Pharmaceuticals (USA), Inc. Email Formats | Percentage |
| FLast@unichemusa.com | 45% |
| Last@unichemusa.com | 8% |
| First@unichemusa.com | 2% |
| FLast@unichemusa.com | 45% |
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Unichem Pharmaceuticals (USA), Inc. is marketing and distributing its own label generic pharmaceutical products in the United States.
Unichem Pharmaceuticals (USA), Inc.'s revenue is estimated to be in the range of $10M$25M
Unichem Pharmaceuticals (USA), Inc.'s revenue is estimated to be in the range of $10M$25M